LIPO
Income statement / Annual
Last year (2023), Lipella Pharmaceuticals Inc.'s total revenue was $449,617.00,
an increase of 144.15% from the previous year.
In 2023, Lipella Pharmaceuticals Inc.'s net income was -$4.62 M.
See Lipella Pharmaceuticals Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$449,617.00
|
$184,156.00
|
$259,347.00
|
$961,683.00
|
$694,748.00
|
| Cost of Revenue |
$3.04 M |
$2.55 M |
$1.46 M |
$975,960.00 |
$682,891.00 |
| Gross Profit |
-$2.59 M |
-$2.36 M |
-$1.20 M |
-$14,277.00 |
$11,857.00 |
| Gross Profit Ratio |
-5.76 |
-12.83 |
-4.62 |
-0.01 |
0.02 |
| Research and Development
Expenses |
$3.04 M
|
$2.55 M
|
$1.46 M
|
$975,960.00
|
$682,891.00
|
| General & Administrative
Expenses |
$2.16 M
|
$226,192.00
|
$718,384.00
|
$42,585.00
|
$65,648.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$2.16 M
|
$226,192.00
|
$718,384.00
|
$42,585.00
|
$65,648.00
|
| Other Expenses |
$0.00 |
-$45.00 |
$57,085.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$2.16 M |
$2.77 M |
$2.18 M |
$1.02 M |
$748,539.00 |
| Cost And Expenses |
$5.20 M |
$2.77 M |
$2.18 M |
$1.02 M |
$748,539.00 |
| Interest Income |
$137,836.00 |
$1,678.00 |
$104.00 |
$3,171.00 |
$334.00 |
| Interest Expense |
$10,848.00 |
$9,612.00 |
$6,834.00 |
$7,965.00 |
$8,391.00 |
| Depreciation &
Amortization |
$1,685.00
|
$2.59 M
|
$1.92 M
|
$56,862.00
|
$53,791.00
|
| EBITDA |
-$4.61 M
|
-$2.59 M
|
$0.00
|
-$53,691.00
|
$334.00
|
| EBITDA Ratio |
-10.25 |
-14.05 |
-7.17 |
-0.06 |
-0.08 |
| Operating Income Ratio
|
-10.56
|
-14.06
|
-7.39
|
-0.06
|
-0.08
|
| Total Other
Income/Expenses Net |
$126,988.00
|
-$7,979.00
|
$50,355.00
|
-$4,794.00
|
-$8,058.00
|
| Income Before Tax |
-$4.62 M |
-$2.60 M |
-$1.87 M |
-$61,656.00 |
-$61,848.00 |
| Income Before Tax Ratio
|
-10.27
|
-14.11
|
-7.19
|
-0.06
|
-0.09
|
| Income Tax Expense |
$0.00 |
-$1,633.00 |
$6,730.00 |
$4,794.00 |
-$53,791.00 |
| Net Income |
-$4.62 M |
-$2.60 M |
-$1.87 M |
-$66,450.00 |
-$61,848.00 |
| Net Income Ratio |
-10.27 |
-14.1 |
-7.22 |
-0.07 |
-0.09 |
| EPS |
-0.77 |
-0.45 |
-0.33 |
-0.0117 |
-0.0109 |
| EPS Diluted |
-0.77 |
-0.45 |
-0.33 |
-0.0117 |
-0.0109 |
| Weighted Average Shares
Out |
$6.00 M
|
$5.74 M
|
$5.74 M
|
$5.69 M
|
$5.69 M
|
| Weighted Average Shares
Out Diluted |
$6.00 M
|
$5.74 M
|
$5.74 M
|
$5.69 M
|
$5.69 M
|
| Link |
|
|
|
|
|
